medigraphic.com
ISSN 0016-3813 (Print)

2019, Number 2

<< Back Next >>

Gac Med Mex 2019; 155 (2)

Efecto de la frecuencia de aplicación de estrógenos locales sobre el grosor endometrial en mujeres posmenopáusicas

Carranza-Lira S, Culebro-Castro YC, Olguín-Cruces VA, Rosales-Ortiz S, Sulvaran-Victoria D, Sánchez-Merino E

Language: Spanish
References: 15
Page: 199-201
PDF size: 166.85 Kb.


ABSTRACT

Introduction: Conjugated estrogens, when used by the vaginal route for the relief of vaginal dryness and atrophy, can produce endometrial changes. Objective: To know the effect of vaginal conjugated estrogens application frequency on endometrial thickness in postmenopausal women. Method: Seventy postmenopausal women with vaginal dryness who received conjugated estrogen cream (0.625 mg/1 g) for 12 weeks were studied. The women were divided according to application frequency as follows: group 1, twice-weekly (n = 35), and group 2, thrice-weekly (n = 35). At baseline and at end-of-treatment, vaginal cytology was examined to determine the estrogenic value, and an endovaginal ultrasound was performed to measure endometrial thickness. The comparison between groups was carried out with Mann Whitney’s U-test, and the comparison between baseline and post-treatment values, with Wilcoxon’s test. Results: Of 70 recruited women, only 38 were studied, 19 in each group, paired by baseline estrogenic value. No difference was found between groups, neither at baseline nor after treatment, in the maturation index, estrogenic value or endometrial thickness. Conclusion: There were no differences in endometrial thickness between the conjugate estrogen cream different application frequencies.


REFERENCES

  1. Carranza-Lira S. Introducción a la endocrinología ginecológica. México: Trillas; 2011.

  2. Carranza-Lira S, Cabrera-López TJ, Estrada Moscoso I, Aguado-Pérez RA. Índice de maduración y sequedad vaginales. Evaluación de dos dosis de estrógenos tópicos vía vaginal. Rev Med Inst Mex Seguro Soc. 2012;50:315-318.

  3. Carranza-Lira S, Amador-Pérez C, MacGregor-Gooch AL. Índice de maduración y sequedad vaginales en la postmenopausia con uso de calcio y calcitriol. Rev Med Inst Mex Seguro Soc. 2012;50:537-540.

  4. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006;4: CD001500.

  5. Carranza-Lira S, Martínez-Chéquer JC, Santa-Rita MT, Ortiz de la-Peña A, Pérez Y, Fernández RL. Endometrial changes according to hormone replacement therapy schedule. Menopause. 1998;5:86-89.

  6. Archer DF. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause. 2010;17:194-203.

  7. Carranza-Lira S, Ortíz-Rodríguez ML, Martínez-Chéquer JC, Santa Rita- Escamilla MT, García-Hernández E, Romo-Aguirre C. Correlación de los hallazgos histopatológicos con las variables ultrasonográficas del endometrio según el peso y distribución del tejido adiposo en la posmenopausia. Ginecol Obstet Mex. 1996;64:517-521.

  8. Ozer A, Ozer S, Kanat-Pektas M. Correlation between transvaginal ultrasound measured endometrial thickness and histopathological findings in Turkish women with abnormal uterine bleeding. J Obstet Gynecol Res. 2016;42:573-578.

  9. Van-Hanegem N, Breijer MC, Khan KS, Clark TJ, Burger MPM, Mol BWJ, et al. Diagnostic evaluation of the endometrium in postmenopausal bleeding: An evidence-based approach. Maturitas. 2011;68:155-164.

  10. Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL. Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiol Biomarkers Prev. 2004;13:1459-1465.

  11. Sheng Q, Yang J Zhao Q, Li F. Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleeding. J Biomed Res. 2016;30:191-196.

  12. Omodei U, Ferrazzia E, Ruggeri C, Palai N, Fallo L, Dordoni D, et al. Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound/hysteroscopic study. Ultrasound Obstet Gynecol. 2000;15:317-320.

  13. Saha TK, Amer SA, Biss J, Thakare H, Williams S, Farrell CT, et al. The validity of transvaginal ultrasound measurement of endometrial thickness: a comparison of ultrasound measurement with direct anatomical measurement. BJOG. 2004;111:1419-1424.

  14. Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13:509-522.

  15. Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;8: CD001500.




2020     |     www.medigraphic.com